Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB-MNCs for Traumatic Fracture Healing
NCT04997590Unknown
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Trial of umbilical cord blood mononuclear cells in nonunion and bone fracture (Fx) (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: Bone formation, Bone defect connection and 1 more. Status: unknown.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
nonunionbone fracture (Fx)
Beyond the preview
Go deeper on NCT04997590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997590.